How Can We Change the World? Vision of the German Federal Agency for Disruptive Innovation (SPRIND)

How Can We Change the World? Vision of the German Federal Agency for Disruptive Innovation (SPRIND)

by Dr. Erik Schäffner

Applied Sciences & Engineering Economics & Finance KJDBusiness innovationKJDDDisruptive innovation
🎙 Dr. Erik Schäffner 👥 7K 📅 October 24, 2025 ⏱ 32 min 👁 105 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

SPRINDdisruptive innovationpublic fundingdeep techpsychedelics

Summary

Dr. Erik Schäffner, a life science analyst at SPRIND (Germany’s Federal Agency for Disruptive Innovation), presents the agency’s mission to fund radical innovations that address societal challenges. He explains that SPRIND, founded in 2019, selects projects based on their potential for breakthrough impact, not immediate financial returns, using taxpayer money to bridge the ‘valley of death’ between basic research and market application. The agency supports a wide range of deep tech fields, including biotech, energy, and materials science, with examples like DNA origami, high-altitude wind turbines, and CO2-neutral cement. Schäffner emphasizes the importance of unconventional methods and interdisciplinary thinking. He also mentions SPRIND’s interest in psychedelics for mental health, noting ongoing conversations but limited public details. The talk includes a Q&A session covering topics like education, competition, and ethical value hierarchies. Overall, the presentation offers insight into how a public agency fosters innovation, with a call for collaboration from researchers and entrepreneurs.

152 words

Critical Evaluation

Value of the Information & Strength of the Argument

The talk provides valuable insights into the operations of a unique public innovation agency, highlighting its criteria for selecting projects based on societal impact rather than profit. Schäffner argues convincingly for the importance of supporting bold ideas and unconventional methods, using concrete examples of funded projects to illustrate the agency’s approach. The argumentation is coherent and well-structured, though it relies on anecdotal evidence and personal experience rather than rigorous data. The speaker’s background as a neuroscientist adds credibility, but the lack of detailed citations or metrics weakens the overall argumentation.

Scientific Rigor, Source Quality, Title Accuracy

The talk is based on the speaker’s professional experience and SPRIND’s official activities, but no specific sources are cited. The description provides a link to the INSIGHT 2023 replay bundle, which is a commercial product, not a scientific source. The title is somewhat grandiose but accurately reflects the talk’s theme of transformative innovation. The content is generally rigorous in its description of SPRIND’s processes, but the lack of verifiable references and the promotional tone for the replay bundle reduce its scientific rigor.

187 words

Title / Content Match

The title is broad and aspirational, matching the talk's focus on SPRIND's vision to change the world through disruptive innovation, though the content is more about the agency's operations than a comprehensive plan.

Quality & Reliability

7/10

The talk is an expert opinion from a neuroscientist and life science analyst at SPRIND, providing an overview of the agency's mission, selection criteria, and funded projects. It is informative but lacks detailed citations or verifiable data, and the speaker acknowledges limitations in discussing psychedelics specifically.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

  • INSIGHT 2023 Replays — Mentioned in the video description as a replay bundle of the conference, not directly cited in the talk.

Concurring Sources

  • SPRIND official website — Provides official information about SPRIND's mission and projects, consistent with the talk.

Contribution & Novelties

The talk provides an insider perspective on how a public agency like SPRIND operates, offering a novel model for funding disruptive innovation with a focus on societal impact. It highlights the potential of psychedelics in mental health, a topic not commonly discussed in public funding contexts.

Pour aller plus loin :

  • SPRIND official website — Official information about the agency’s mission and projects.
  • DARPA — The US defense agency that inspired SPRIND, relevant for understanding the model.
  • Psychedelic therapy — Overview of the therapeutic use of psychedelics, relevant to the talk’s discussion.

92 words

Radar Profile

The radar profile shows moderate scores across all dimensions, with slightly higher scores in information quantity and quality, reflecting the talk's informative but not deeply technical nature. The low technical level suggests it is accessible to a general audience.

Reliability 6/10

💬 No comments were provided for analysis.